New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 21, 2014
08:04 EDTCLSNCelsion formalizing program to develop ThermoDox
Celsion announced that the company is formalizing a program to pursue the development of ThermoDox to investigate applications for treating brain cancer tumors, notably Glioblastoma Multiforme or GBM. In addition to jointly submitting multiple grant applications, the company is also pursuing preclinical studies in collaboration with Costas D. Arvanitis at the Brigham and Women's Hospital and Harvard Medical School.
News For CLSN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 17, 2015
10:03 EDTCLSNHigh option volume stocks
High option volume stocks: EWC DF WPX CLSN TE CMA SWI CE VRSN USG
July 15, 2015
10:20 EDTCLSNCelsion rallies after firm sets $12 target while stock near $2 per share
Subscribe for More Information
10:01 EDTCLSNOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:51 EDTCLSNCelsion initiated with a Buy at Maxim
Target $12.
July 14, 2015
19:05 EDTCLSNOn The Fly: Pre-market Movers
UP AFTER EARNINGS: CSX (CSX), up 3.5%. ALSO HIGHER: Receptos (RCPT), up 10.2% following deal to be acquired by Celgene (CELG)... Celgene is up 5.8% after announcing acquisition of Receptos... Celsion (CLSN), up 8.8% after being initiated with a Buy at BTIG... Aratana Therapeutics (PETX), up 10% after results of pivotal study of AT-003. DOWN AFTER EARNINGS: Peregrine (PPHM), down 3%... Yum! Brands (YUM), down marginally. ALSO LOWER: Allegheny Technologies (ATI), down 9.3% after providing second quarter EPS guidance... Mead Johnson (MJN), down 4.8% after reducing fiscal 2015 EPS guidance.
06:09 EDTCLSNCelsion initiated with a Buy at BTIG
Subscribe for More Information
July 13, 2015
19:04 EDTCLSNOn The Fly: After Hours Movers
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use